ensg ensmusg nmnmnm nm npnp np cd also know tnfrsf cell membran protein tumor necrosi factor receptor famili tumor marker receptor express activ rest cell traf traf interact receptor mediat signal transduct lead activ nfkappab posit regul apoptosi also show limit prolif potenti autoreact cd effector cell protect bodi autoimmun two altern splice transcript variant gene encod distinct isoform report cd associ anaplast larg cell lymphoma express embryon carcinoma seminoma thus use marker distinguish germ cell tumor cd cd also express reedsternberg cell typic hodgkin lymphoma cd target fda approv therapeut brentuximab vedotin adcetri approv use brentuximab vedotin also current studi recommend treat cd show interact traf traf articl incorpor text unit state nation librari medicin public domain